923282-64-8 Usage
Uses
Used in Organic Synthesis:
7-Chloro-1H-pyrazolo[4,3-d]pyrimidine serves as a key building block in organic synthesis, contributing to the creation of a variety of complex organic molecules with potential applications in various fields.
Used in Pharmaceutical Research:
In pharmaceutical research, 7-Chloro-1H-pyrazolo[4,3-d]pyrimidine is utilized for the synthesis of biologically active molecules and pharmaceutical drugs, playing a crucial role in the development of new therapeutic agents.
Used as a Research Tool in Structure-Activity Relationship Studies:
7-Chloro-1H-pyrazolo[4,3-d]pyrimidine is employed as a research tool to investigate the structure-activity relationships of various biological targets, aiding in the understanding of how molecular structure influences biological activity.
Used in Laboratories and Research Facilities:
Available commercially, 7-Chloro-1H-pyrazolo[4,3-d]pyrimidine is widely used in laboratories and research facilities for a range of scientific purposes, including the development and testing of new chemical compounds and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 923282-64-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,3,2,8 and 2 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 923282-64:
(8*9)+(7*2)+(6*3)+(5*2)+(4*8)+(3*2)+(2*6)+(1*4)=168
168 % 10 = 8
So 923282-64-8 is a valid CAS Registry Number.
923282-64-8Relevant academic research and scientific papers
ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP-1) INHIBITORS AND USES THEREOF
-
Paragraph 0507, (2019/03/17)
Disclosed herein are methods and compounds of augmenting and enhancing the production of type I IFNs in vivo. In some embodiments, the compounds disclosed herein are ENPP-1 inhibitors, pharmaceutical compositions, and methods for the treatment of cancer or a viral infection.
Pyrazolo pyrimidines useful as aurora kinase inhibitors
-
Page/Page column 84-85, (2010/11/25)
The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: wherein one of is a double bond, as valency permits; and R2, R4, X1A, X2A, X1B, X2B, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.
